Vesna Ivanović

938 total citations
22 papers, 530 citations indexed

About

Vesna Ivanović is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Vesna Ivanović has authored 22 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Vesna Ivanović's work include TGF-β signaling in diseases (10 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Vesna Ivanović is often cited by papers focused on TGF-β signaling in diseases (10 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Vesna Ivanović collaborates with scholars based in United States, Serbia and Russia. Vesna Ivanović's co-authors include I. Bernard Weinstein, Nicholas E. Geacintov, Miroslav Demajo, Zora Nešković‐Konstantinović, Dragica Nikolić‐Vukosavljević, Nataša Todorović‐Raković, Hiroshi Yamasaki, Vesna Subota, Ronald G. Harvey and A.M. Jeffrey and has published in prestigious journals such as Nature, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Vesna Ivanović

20 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vesna Ivanović United States 10 379 191 190 95 67 22 530
Sheo S. Singh United States 6 434 1.1× 87 0.5× 97 0.5× 88 0.9× 91 1.4× 6 639
W. Barkley Butler United States 10 372 1.0× 128 0.7× 182 1.0× 42 0.4× 52 0.8× 14 690
Motoko Inomata Japan 13 269 0.7× 60 0.3× 113 0.6× 124 1.3× 17 0.3× 39 658
K.A. BIEDERMANN United States 7 506 1.3× 248 1.3× 199 1.0× 50 0.5× 81 1.2× 9 822
Sherry L. Ralston United States 10 272 0.7× 173 0.9× 127 0.7× 77 0.8× 71 1.1× 14 533
Henriette Brésil France 13 512 1.4× 337 1.8× 131 0.7× 35 0.4× 89 1.3× 21 737
Stephen C. Mann United States 5 328 0.9× 35 0.2× 352 1.9× 53 0.6× 14 0.2× 5 569
Clémentine Féau United States 9 235 0.6× 34 0.2× 54 0.3× 77 0.8× 15 0.2× 13 469
K.L. Eneff United States 7 307 0.8× 87 0.5× 33 0.2× 40 0.4× 24 0.4× 7 438
Ling‐Hua Meng United States 10 323 0.9× 55 0.3× 128 0.7× 46 0.5× 11 0.2× 15 427

Countries citing papers authored by Vesna Ivanović

Since Specialization
Citations

This map shows the geographic impact of Vesna Ivanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesna Ivanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesna Ivanović more than expected).

Fields of papers citing papers by Vesna Ivanović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesna Ivanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesna Ivanović. The network helps show where Vesna Ivanović may publish in the future.

Co-authorship network of co-authors of Vesna Ivanović

This figure shows the co-authorship network connecting the top 25 collaborators of Vesna Ivanović. A scholar is included among the top collaborators of Vesna Ivanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesna Ivanović. Vesna Ivanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ivanović, Vesna, Nasta Tanić, Zorka Milovanović, et al.. (2016). Case with Triple-Negative Breast Cancer Shows Overexpression of Both Cfos and Tgf-β1 in Node-Positive Tissue. Personalized Medicine. 13(6). 523–530. 2 indexed citations
3.
Ivanović, Vesna, Nasta Tanić, Zorka Milovanović, et al.. (2009). Quantification of transforming growth factor beta 1 levels in metastatic axillary lymph node tissue extracts from breast cancer patients: a new specimen source.. PubMed. 31(5). 288–95. 6 indexed citations
4.
Nikolić, Goran M., et al.. (2007). Isolated aneurysm of the internal iliac artery and disorders of the pelvic organs functions. Vojnosanitetski pregled. 64(5). 357–360.
5.
Ivanović, Vesna, et al.. (2006). Role of transforming growth factor-β1 in breast carcinogenesis. Archive of oncology. 14(3-4). 122–125. 1 indexed citations
6.
Nikolić‐Vukosavljević, Dragica, et al.. (2005). Plasma TGF-β1-related survival of postmenopausal metastatic breast cancer patients. Clinical & Experimental Metastasis. 21(7). 581–585. 17 indexed citations
7.
Ivanović, Vesna. (2005). Aberrations of growth factors as biomarkers of cancer progression. Archive of oncology. 13(3-4). 121–123. 1 indexed citations
8.
Ivanović, Vesna, Miroslav Demajo, Nataša Todorović‐Raković, et al.. (2004). Localization of recognition site between transforming growth factor- (TGF-) and TGF receptor type II: possible implications in breast cancer. Medical Hypotheses. 62(5). 727–732. 3 indexed citations
9.
Ivanović, Vesna, Nataša Todorović‐Raković, Miroslav Demajo, et al.. (2003). Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progression. European Journal of Cancer. 39(4). 454–461. 108 indexed citations
10.
Todorović‐Raković, Nataša, Vesna Ivanović, Miroslav Demajo, Zora Nešković‐Konstantinović, & Dragica Nikolić‐Vukosavljević. (2003). Elevated plasma levels of TGF-beta1 in patients with locally advanced breast cancer related to other clinical stages. Archive of oncology. 11(3). 131–133. 4 indexed citations
11.
Todorović‐Raković, Nataša, Vesna Ivanović, Miroslav Demajo, et al.. (2002). TGF-beta1 in breast cancer-estrogen regulation. Archive of oncology. 10(3). 164–165. 1 indexed citations
12.
Ivanović, Vesna, et al.. (1990). Detection of Cross-Reacting Idiotypes in Sera of Lymphoma Patients by Inverse Monoclonal Radioimmunoassay. Acta Haematologica. 84(2). 64–67. 5 indexed citations
13.
Ivanović, Vesna, et al.. (1985). Pinacolyl methylphosphonochloridate: in vitro covalent binding to DNA and mutagenicity in the Ames test. Mutation Research Letters. 142(1-2). 9–12. 5 indexed citations
14.
Ivanović, Vesna & I. Bernard Weinstein. (1982). Benzo[a]pyrene and other inducers of cytochrome P1-450 inhibit binding of epidermal growth factor to cell surface receptors. Carcinogenesis. 3(5). 505–510. 33 indexed citations
15.
Ivanović, Vesna & I. Bernard Weinstein. (1981). Glucocorticoids and benzo(a)pyrene have opposing effects on EGF receptor binding. Nature. 293(5831). 404–406. 23 indexed citations
16.
Ivanović, Vesna & I. Bernard Weinstein. (1980). Genetic factors in Escherichia coli that affect cell killing and mutagenesis induced by benzo(a)pyrene-7,8-dihydrodiol 9,10-oxide.. PubMed. 40(10). 3508–11. 12 indexed citations
17.
Geacintov, Nicholas E., et al.. (1978). Electric linear dichroism study on the orientation of benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide covalently bound to DNA. Biochemistry. 17(24). 5256–5262. 84 indexed citations
18.
Ivanović, Vesna, Nicholas E. Geacintov, Hiroshi Yamasaki, & I. Bernard Weinstein. (1978). DNA and RNA adducts formed in hamster embryo cell cultures exposed to benzo[a]pyrene. Biochemistry. 17(9). 1597–1603. 72 indexed citations
19.
Ivanović, Vesna, Nicholas E. Geacintov, A.M. Jeffrey, et al.. (1978). Cell and microsome mediated binding of 7, 12-dimethylbenz(a)anthracene to DNA studied by fluorescence spectroscopy. Cancer Letters. 4(3). 131–140. 44 indexed citations
20.
Ivanović, Vesna, Nicholas E. Geacintov, & I. Bernard Weinstein. (1976). Cellular binding of benzo(a)pyrene to DNA characterized by low temperature fluorescence. Biochemical and Biophysical Research Communications. 70(4). 1172–1179. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026